Avalon Pharmaceuticals Balance Sheet
View: Annual
| Assets | Dec 08 | Dec 07 | Dec 06 |
|---|---|---|---|
| Current Assets | |||
| Cash | 4.9 | 6.3 | 3.1 |
| Net Receivables | 0.0 | 0.4 | 0.9 |
| Inventories | -- | -- | -- |
| Other Current Assets | 1.3 | 16.4 | 10.7 |
| Total Current Assets | 6.2 | 23.1 | 14.7 |
| Net Fixed Assets | 5.9 | 7.3 | 8.9 |
| Other Noncurrent Assets | 0.0 | 6.9 | 7.7 |
| Total Assets | 12.1 | 37.3 | 31.4 |
| Liabilities and Shareholder's Equity | Dec 08 | Dec 07 | Dec 06 |
| Current Liabilities | |||
| Accounts Payable | 1.6 | 1.1 | 1.9 |
| Short-Term Debt | 3.0 | 1.2 | 1.5 |
| Other Current Liabilities | 2.3 | 2.4 | 2.3 |
| Total Current Liabilities | 6.9 | 4.7 | 5.6 |
| Long-Term Debt | 0.0 | 6.0 | 7.2 |
| Other Noncurrent Liabilities | 0.4 | 0.4 | 0.7 |
| Total Liabilities | 7.3 | 11.1 | 13.5 |
|
Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | 0.0 | -- |
| Common Stock Equity | 4.8 | 26.2 | 17.9 |
| Total Equity | 4.8 | 26.2 | 17.9 |
| Shares Outstanding (mil.) | 20.4 | 20.4 | 20.4 |
© 2009 Morningstar, Inc. Financial Data provided by
